Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. (Q48948533)

17 February 2018

title

Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. (English)

1 reference

17 February 2018

0 references

Sheng JG

1

1 reference

17 February 2018

Mrak RE

series ordinal

2

1 reference

17 February 2018

Griffin WS

series ordinal

3

1 reference

17 February 2018

publication date

1 August 1996

1 reference

17 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

17 February 2018

volume

22

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

334-341

1 reference

17 February 2018

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Glial cytokines in Alzheimer's disease: review and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1996.TB01112.X

10.1111/J.1365-2990.1996.TB01112.X

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

8875468

1 reference

17 February 2018